A novel therapeutic agent for heart failure, atrial fibrillation and chronic kidney disease, ryanodine receptor 2 inhibitor, M201-A
Company Philosophy
Business Strategy
Development Products
News Release
Company Profile
Recruitment
Licensing/Contact Us
Menu
Home/Licensing/Contact Us
Please fill in each item, check the contents and press the ‘Confirm’ button.
Please fill in the form after confirming the contents.